Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Viruses ; 11(12)2019 11 26.
Artigo em Inglês | MEDLINE | ID: mdl-31779110

RESUMO

The human cytomegalovirus (HCMV) terminase complex is part of DNA-packaging machinery that delivers a unit-length genome into a procapsid. Sequence comparison of herpesvirus homologs allowed us to identify a potential LATLNDIERFL and zinc finger pattern in N-terminal part of pUL56. Recombinant viruses were generated with specific serine or alanine substitutions in these putative patterns. We identified a LATLNDIERFL pattern characteristic of LAGLIDADG homing endonucleases and a metal-binding pattern involving the cysteine and histidine residues C191-X2-C194-X22-C217-X-H219 (CCCH) close to the region conferring letermovir resistance. These patterns are crucial for viral replication, suggesting that they are essential for pUL56 structure and function. Thus, these patterns represent potential targets for the development of new antivirals such as small molecules or peptides and may allow to better understand the letermovir mechanism of action.


Assuntos
Citomegalovirus/enzimologia , Farmacorresistência Viral/genética , Endodesoxirribonucleases/genética , Proteínas Estruturais Virais/genética , Acetatos/farmacologia , Sequência de Aminoácidos , Antivirais/farmacologia , Citomegalovirus/genética , Citomegalovirus/fisiologia , Empacotamento do DNA , Humanos , Domínios Proteicos , Quinazolinas/farmacologia , Alinhamento de Sequência , Replicação Viral , Dedos de Zinco/genética
2.
Antiviral Res ; 98(1): 130-4, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23415883

RESUMO

Long-term exposure to antiviral therapy in immunocompromised patients favors emergence of human cytomegalovirus (HCMV) resistance mutations. Two new UL54 DNA polymerase mutations (deletion of codon 524 and N408S substitution) identified in a kidney recipient and a bone marrow recipient respectively were characterized. Marker transfer experiment through recombination into a HCMV AD169 BAC demonstrated del524 and mutation N408S confer GCV and CDV resistance. These results suggest continued mutation of UL54 under selective antiviral pressure. Characterization of each new mutation is thus required to inform genotypic assays and to better understand the functional regions of UL54 for the development of novel antivirals.


Assuntos
Antivirais/uso terapêutico , Infecções por Citomegalovirus/tratamento farmacológico , Citomegalovirus/efeitos dos fármacos , Citomegalovirus/enzimologia , DNA Polimerase Dirigida por DNA/genética , Farmacorresistência Viral , Mutação , Proteínas Virais/genética , Transplante de Medula Óssea/efeitos adversos , Cromossomos Artificiais Bacterianos/genética , Cromossomos Artificiais Bacterianos/metabolismo , Citomegalovirus/genética , Infecções por Citomegalovirus/etiologia , Infecções por Citomegalovirus/virologia , DNA Polimerase Dirigida por DNA/metabolismo , Humanos , Transplante de Rim/efeitos adversos , Modelos Moleculares , Fenótipo , Proteínas Virais/metabolismo
3.
Antivir Ther ; 14(5): 663-72, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19704169

RESUMO

BACKGROUND: The human cytomegalovirus (HCMV) nuclear UL27 protein (pUL27) could be involved at the stage of nuclear egress. Maribavir is a new anti-HCMV drug that targets nuclear egress through direct inhibition of the HCMV serine-threonine kinase, UL97 protein (pUL97). Because maribavir-resistance-related mutations are observed in both proteins, pUL27 is thought to interfere with pUL97 activity; however, its mechanism of action remains unclear. METHODS: As there is no available crystal structure for pUL27 or any known structures of its homologous proteins, we attempted to identify pUL27 functional domains by sequence analysis, identification of conserved domains, structure prediction and matching with previously known maribavir resistance mutations. RESULTS: The UL27 sequence analysis of 20 HCMV wild-type strains and 8 ganciclovir-resistant HCMV strains allowed us to describe four conserved domains, to localize the putative phosphorylation sites and to identify protein-protein interface domains, suggesting that pUL27 could interact with either pUL97 or itself. CONCLUSIONS: Although the function of pUL27 is still unknown in the HCMV replication cycle, our approach identified target domains that appeared to be essential to the function of pUL27. This work provides a better understanding on the relative importance of each pUL27 mutation and could form the basis of later comparison analyses, when a three-dimensional structure of a pUL27 homologue will be available.


Assuntos
Sequência Conservada/genética , Citomegalovirus/enzimologia , Fosfotransferases (Aceptor do Grupo Álcool)/química , Sequência de Aminoácidos , Antivirais/farmacologia , Benzimidazóis/farmacologia , Citomegalovirus/efeitos dos fármacos , Citomegalovirus/genética , DNA Viral/análise , DNA Viral/isolamento & purificação , Farmacorresistência Viral/genética , Humanos , Dados de Sequência Molecular , Mutação , Fosfotransferases (Aceptor do Grupo Álcool)/efeitos dos fármacos , Fosfotransferases (Aceptor do Grupo Álcool)/genética , Ribonucleosídeos/farmacologia , Alinhamento de Sequência , Análise de Sequência de DNA , Relação Estrutura-Atividade
4.
Methods Mol Biol ; 462: 111-33, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19160664

RESUMO

Lipid structure and dynamics are of first importance for cellular function. Lipids such as phosphatidyl inositol (PtdIns) are essential in signaling pathways, as they are recognition sites at the membrane surface. Their headgroup or chain structure appears to be crucial for such a signaling role. Other lipids such as cholesterol and sphingomyelin are key molecules in maintaining membrane integrity and are the building blocks of membrane domains, such as "rafts." It is essential to have techniques that can decipher both the structure and dynamics of various classes of lipids. With its liquid-state and solid-state facets, NMR is a very powerful tool for such a determination. We show that lipids extracted from membranes and dissolved in organic solvents can reveal their molecular structure when observed with multinuclear one-dimensional or two-dimensional NMR. We also show that multinuclear solid-state NMR provides information on the nature of the membrane phase (lamellar, hexagonal, isotropic, etc.), its dynamics (fluid or gel, or liquid ordered with cholesterol), and the molecular structure of embedded lipids when using the magic angle spinning apparatus. Typical examples of relatively simple experiments are shown both with liquid- and solid-state NMR of lipids.


Assuntos
Lipídeos/análise , Espectroscopia de Ressonância Magnética/métodos , Membrana Celular/química , Colesterol/análise , Fosfatidilinositóis/análise , Soluções , Esfingomielinas/análise
5.
Antivir Ther ; 13(5): 643-54, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18771048

RESUMO

BACKGROUND: Benzimidazole D-ribonucleosides inhibit DNA packaging during human cytomegalovirus (HCMV) replication. Although they have been shown to target pUL56 and pUL89 (the large and small subunits of the HCMV terminase, respectively) their mechanism of action is not yet fully understood. We aimed here to better understand HCMV DNA maturation and the mechanism of action of benzimidazole derivatives. METHODS: The HCMV pUL56 protein was studied by sequence analysis of the HCMV UL56 gene and herpesvirus counterparts combined with primary structure analysis of the corresponding amino acid sequences. RESULTS: The UL56 sequence analysis of 45 HCMV strains and counterparts among herpesviruses allowed the identification of 12 conserved regions. Moreover, comparison with the product of gene 49 (gp49) of bacteriophage T4 suggested that the pUL56 zinc finger is localized close to the dimerization site of pUL56, providing a spatial organization of the catalytic site that allows recognition and cleavage of DNA. CONCLUSIONS: This study provides a basis to investigate the mechanism of concatemeric DNA cleavage and a biochemical basis for DNA packaging inhibition by benzimidazole derivatives.


Assuntos
Benzimidazóis/farmacologia , Citomegalovirus/efeitos dos fármacos , Citomegalovirus/metabolismo , Ribonucleosídeos/farmacologia , Proteínas Estruturais Virais/química , Proteínas Estruturais Virais/metabolismo , Sequência de Aminoácidos , Benzimidazóis/química , Células Cultivadas , Citomegalovirus/genética , Citomegalovirus/crescimento & desenvolvimento , DNA Viral/metabolismo , Dimerização , Fibroblastos , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Ribonucleosídeos/química , Análise de Sequência de DNA , Proteínas Estruturais Virais/genética , Montagem de Vírus/efeitos dos fármacos
6.
Antivir Ther ; 12(2): 217-32, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17503664

RESUMO

INTRODUCTION: Benzimidazole D-ribonucleosides inhibit DNA packaging during human cytomegalovirus (HCMV) replication. Although they have been shown to target pUL56 and pUL89, the large and small subunits of the HCMV terminase respectively, their mechanism of action is not yet fully understood. METHODS AND RESULTS: To better understand HCMV DNA maturation and the mechanism of action of benzimidazole derivatives, we studied the HCMV pUL89 protein by a genetic approach combined with primary structure analysis. The pUL89 sequence analysis of 25 HCMV strains and counterparts among herpesviruses allowed identification of 12 conserved regions. We also built a three-dimensional model of the pUL89 ATPasic catalytic site, including ATPase motor motifs 1, II and III, that may facilitate the development of future antiviral drugs active against HCMV. Finally, we identified several putative functional domains in pUL89, such as pUL89 zinc finger (pUL89-ZF), DNA cutting sites and portal binding sites, that are probably involved in CMV DNA cleavage and packaging.


Assuntos
Adenosina Trifosfatases/química , Citomegalovirus/enzimologia , Empacotamento do DNA , DNA Viral/metabolismo , Endodesoxirribonucleases/química , Proteínas Virais/química , Adenosina Trifosfatases/antagonistas & inibidores , Adenosina Trifosfatases/genética , Adenosina Trifosfatases/metabolismo , Sequência de Aminoácidos , Antivirais/química , Antivirais/farmacologia , Domínio Catalítico , Sequência Conservada , Citomegalovirus/efeitos dos fármacos , Citomegalovirus/genética , Citomegalovirus/crescimento & desenvolvimento , Empacotamento do DNA/efeitos dos fármacos , DNA Viral/efeitos dos fármacos , Desenho de Fármacos , Endodesoxirribonucleases/antagonistas & inibidores , Endodesoxirribonucleases/genética , Endodesoxirribonucleases/metabolismo , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Polimorfismo Genético , Conformação Proteica , Estrutura Terciária de Proteína , Alinhamento de Sequência , Proteínas Virais/antagonistas & inibidores , Proteínas Virais/genética , Proteínas Virais/metabolismo , Replicação Viral/efeitos dos fármacos , Dedos de Zinco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...